Stockscreener 앱 받기
20.46
0.05%
0.01
전일 마감가:
$20.45
열려 있는:
$20.39
하루 거래량:
4.48M
Relative Volume:
1.17
시가총액:
$3.74B
수익:
$644.86M
순이익/손실:
$196.05M
주가수익비율:
20.85
EPS:
0.9812
순현금흐름:
$317.50M
1주 성능:
+2.20%
1개월 성능:
+4.49%
6개월 성능:
-52.95%
1년 성능:
-64.13%
1일 변동 폭
$19.79
$20.76
1주일 범위
$19.62
$21.07
52주 변동 폭
$17.15
$76.51
Doximity Inc Stock (DOCS) Company Profile
명칭
Doximity Inc
전화
(650) 549-4330
주소
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS vs VEEV, BTSG, TEM, HQY, HNGE
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
20.46 | 3.74B | 644.86M | 196.05M | 317.50M | 0.9812 |
VEEV
Veeva Systems Inc
|
153.30 | 24.90B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
66.25 | 13.00B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
50.84 | 9.13B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
85.21 | 7.12B | 1.34B | 230.70M | 440.96M | 2.6695 |
HNGE
Hinge Health Inc
|
69.42 | 5.37B | 646.34M | -512.40M | 202.76M | -6.6871 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-20 | 다운그레이드 | Truist | Buy → Hold |
| 2026-04-08 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2026-02-09 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2026-02-06 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2026-01-20 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2026-01-09 | 개시 | RBC Capital Mkts | Outperform |
| 2026-01-08 | 업그레이드 | Truist | Hold → Buy |
| 2025-12-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-11-21 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2025-11-13 | 개시 | BMO Capital Markets | Market Perform |
| 2025-10-27 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2025-10-10 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2025-10-01 | 다운그레이드 | Goldman | Neutral → Sell |
| 2025-07-09 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-06-02 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2025-02-07 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | 개시 | Stephens | Equal-Weight |
| 2024-12-04 | 개시 | Mizuho | Neutral |
| 2024-11-15 | 개시 | Goldman | Neutral |
| 2024-11-14 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2024-08-09 | 업그레이드 | Needham | Hold → Buy |
| 2024-07-18 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2024-01-03 | 개시 | Barclays | Equal Weight |
| 2024-01-02 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2023-08-09 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2023-08-09 | 다운그레이드 | Needham | Buy → Hold |
| 2023-08-03 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | 개시 | Wells Fargo | Overweight |
| 2022-10-24 | 개시 | Evercore ISI | In-line |
| 2022-10-13 | 개시 | BTIG Research | Neutral |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | 개시 | Truist | Hold |
| 2022-08-05 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-07-28 | 개시 | Berenberg | Buy |
| 2022-05-18 | 재확인 | BofA Securities | Neutral |
| 2022-05-18 | 재확인 | Goldman | Buy |
| 2022-05-18 | 재확인 | Guggenheim | Buy |
| 2022-05-18 | 재확인 | Jefferies | Buy |
| 2022-05-18 | 재확인 | Morgan Stanley | Equal-Weight |
| 2022-05-18 | 재확인 | Needham | Buy |
| 2022-04-07 | 개시 | Guggenheim | Buy |
| 2022-04-04 | 개시 | BofA Securities | Neutral |
| 2022-02-11 | 개시 | Goldman | Buy |
| 2021-12-14 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2021-12-02 | 개시 | Jefferies | Buy |
| 2021-11-17 | 개시 | Robert W. Baird | Outperform |
| 2021-11-10 | 재확인 | Canaccord Genuity | Buy |
| 2021-11-10 | 재확인 | Goldman | Neutral |
| 2021-11-10 | 재확인 | Morgan Stanley | Equal-Weight |
| 2021-11-10 | 재확인 | Needham | Buy |
| 2021-11-10 | 재확인 | Piper Sandler | Overweight |
| 2021-08-26 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-07-19 | 개시 | Canaccord Genuity | Buy |
| 2021-07-19 | 개시 | Goldman | Neutral |
| 2021-07-19 | 개시 | JP Morgan | Overweight |
| 2021-07-19 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-07-19 | 개시 | Piper Sandler | Overweight |
| 2021-07-19 | 개시 | Raymond James | Outperform |
| 2021-07-19 | 개시 | SVB Leerink | Outperform |
| 2021-07-19 | 개시 | William Blair | Outperform |
모두보기
Doximity Inc 주식(DOCS)의 최신 뉴스
Doximity (DOCS) CFO discloses 501,549 shares, including 499,722 RSUs, on Form 3 - Stock Titan
Doximity (DOCS) President Steven Zatz receives 55,524 restricted stock units - Stock Titan
Doximity (NYSE: DOCS) president discloses 822 Class A shares - Stock Titan
Doximity Inc (DOCS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Doximity Inc (DOCS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Doximity Inc (DOCS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Doximity Inc (DOCS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Doximity Inc (DOCS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Doximity Inc (DOCS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Doximity Inc (DOCS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Doximity Inc (DOCS) Institutional Confidence - TradingKey
Doximity (DOCS) Advances While Market Declines: Some Information for Investors - Yahoo Finance Singapore
Doximity, Inc. (DOCS) Stock Analysis: Exploring a 26.85% Potential Upside in Health Information Services - DirectorsTalk Interviews
Responsive Playbooks and the DOCS Inflection - Stock Traders Daily
Y Intercept Hong Kong Ltd Invests $9 Million in Doximity, Inc. $DOCS - MarketBeat
Doximity, Inc. $DOCS Shares Purchased by Rhenman & Partners Asset Management AB - MarketBeat
Doximity (DOCS) up 11.2% since last earnings report: Can it continue? - MSN
Doximity: Cheaper, But Growth Is Still Missing (NYSE:DOCS) - Seeking Alpha
Is Doximity Struggling After Revenue Miss? - Kalkine Media
Doximity (DOCS) Up 11.2% Since Last Earnings Report: Can It Continue? - Yahoo Finance Australia
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Doximity (DOCS) and Axsome Therapeutics (AXSM) - The Globe and Mail
Doximity (DOCS) Institutional Ownership 2026 $DOCS - MarketBeat
DOCS Investors Have Opportunity to Join Doximity, Inc. Fraud Inv - GuruFocus
DOCS Investors Have Opportunity to Join Doximity, Inc. Fraud Investigation with the Schall Law Firm - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc.DOCS - PR Newswire
Doximity interim PAO Sitaram Siddharth sells $49,882 in shares By Investing.com - Investing.com Canada
Doximity interim PAO Sitaram Siddharth sells $49,882 in shares - Investing.com UK
symbol__ Stock Quote Price and Forecast - CNN
Doximity (DOCS) interim PAO trades shares under 10b5-1 plan, exercises options - Stock Titan
AI Margin Pressure And Legal Probe Might Change The Case For Investing In Doximity (DOCS) - simplywall.st
Doximity hits an all-time low after Q4 results; KeyBanc downgrades - MSN
[144] Doximity, Inc. SEC Filing - Stock Titan
Capital World Investors Has $250.40 Million Holdings in Doximity, Inc. $DOCS - MarketBeat
DOCS (NASDAQ: DOCS) Form 144 reports 2,444-share sale via exercise - Stock Titan
Doximity shares drop 23% after missing revenue targets and AI investment warning - Pluang
Doximity, Inc. (DOCS) Stock Analysis: Exploring a 22.15% Potential Upside in the Healthcare Information Sector - DirectorsTalk Interviews
Doximity(DOCS) Stock Options Chain | Quotes & News - Moomoo
Law firm investigates Doximity officers for possible shareholder rights breaches - Pluang
BofA Securities Maintains Doximity(DOCS.US) With Buy Rating, Cuts Target Price to $38 - Moomoo
DOCS Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
2026-06-05 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Doximity, Inc. (DOCS) and Encourages Shareholders to Learn More About the Investigation | NYSE:DOCS | Press Release - Stockhouse
Doximity stock falls on Q4 earnings miss, revenues beat, margins down - MSN
Legal & General Group Plc Sells 54,024 Shares of Doximity, Inc. $DOCS - MarketBeat
BNP Paribas Financial Markets Raises Position in Doximity, Inc. $DOCS - MarketBeat
Doximity, Inc. (DOCS) Investigation: Bronstein, Gewirtz & Grossma - The National Law Review
Doximity, Inc. (DOCS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Doximity (NYSE:DOCS) Downgraded by Zacks Research to Strong Sell - MarketBeat
Workday and Doximity shares are soaring, what you need to know - MSN
Bronstein, Gewirtz & Grossman, LLC Encourages Doximity, Inc. (DOCS) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Understanding the Setup: (DOCS) and Scalable Risk - Stock Traders Daily
Doximity Inc (DOCS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.21%
자본화:
|
볼륨(24시간):